Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1996 Jul;87(7):757–764. doi: 10.1111/j.1349-7006.1996.tb00289.x

Transduction of the Macrophage Colony‐stimulating Factor Gene into Human Multidrug Resistant Cancer Cells: Enhanced Therapeutic Efficacy of Monoclonal Anti‐P‐glycoprotein Antibody in Nude Mice

Saburo Sone 1,✉, Takashi Tsuruo 2, Shigeo Sato 3, Seiji Yano 1, Yasuhiko Nishioka 1, Tsutomu Shinohara 1
PMCID: PMC5921165  PMID: 8698627

Abstract

To develop a therapeutic modality for overcoming multidrug‐resistant (MDR) cancer with anti‐MDR1 antibody, we examined the effect of macrophage colony‐stimulating factor (M‐CSF) gene transfection into MDR AD10 cells on therapy of MDR cancer with anti‐MDR1 antihody (MRK17) in nude mice. MDR human ovarian cancer (AD10) cells were transduced with the human M‐CSF gene inserted into an expression vector to establish gene‐modified cells capable of producing low (ML‐AD10), intermediate (MM‐AD10) and high (MH‐AD10) amounts of M‐CSF. Systemic administration of MRK17 resulted in significant dose‐dependent inhibition of subcutaneous growth of ML‐AD10 tumors. In contrast, systemic administration of recombinant M‐CSF in combination with MRK17 did not augment the therapeutic efficacy of MRK17 alone, but rather promoted the growth of the parent AD10 cells. To test the efficacy of in vivo M‐CSF gene therapy combined with antibody, we mixed the parent AD10 cells with MH‐AD10 cells producing a large amount of M‐CSF, and inoculated the mixed cells subcutaneously. Treatment with MRK17 inhibited growth of the mixed cells more than that of the parent cells alone. Thus, combined therapy with anti‐MDR1 mAb and M‐CSF gene modification of MDR cancer cells may provide a new immunotherapeutic modality for overcoming MDR in humans.

Keywords: Anti‐P‐glycoprotein antibody, Multidrug resistance, M‐CSF, Gene therapy

Full Text

The Full Text of this article is available as a PDF (497.5 KB).

REFERENCE

  • 1.Safa , A. R. , Glover , C. J. , Meyers , M. B. , Biedler , J. L. and Felsted , R. L.Vinblastine photoaffinity labeling of a high molecular weight surface membrane glycoprotein specific for multidrug‐resistant cells . J. Biol. Chem ., 261 , 6137 – 6140 ( 1986. ). [PubMed] [Google Scholar]
  • 2.Cornwell , M. M. , Safa , A. R. , Felsted , R. L. , Gottesman , M. M. and Pastan , I.Membrane vesicles from multidrug resistant human cancer cells contain a specific 150‐ to 170‐ kDa protein detected by photoaffinity labeling . Proc. Natl. Acad. Sci. USA , 83 , 3847 – 3850 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Hamada , H. and Tsuruo , T.Functional role for the 170‐to 180‐kDa glycoprotein specific to drug‐resistant tumor cells as revealed by monoclonal antibodies . Proc. Natl. Acad. Sci. USA , 83 , 7785 – 7789 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Riordan , J. R. and Ling , V.Genetic and biochemical characterization of multidrug resistance . Pharmacol. Ther ., 28 , 51 – 75 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 5.Tsuruo , T.Mechanisms of multidrug resistance and implications for therapy . Jpn. J. Cancer Res ., 79 , 285 – 296 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Bell , D. R. , Gerlach , J. H. , Kartner , R. N. , Buick , R. N. and Ling , V.Detection of P‐glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance . J. Clin. Oncol ., 3 , 311 – 315 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 7.Fojo , A. T. , Ueda , E. K. , Slamon , D. J. , Poplack , D. G. , Gottesman , M. M. and Pastan , I.Expression of a multidrug resistance gene in human tumors and tissues . Proc. Natl. Acad. Sci. USA , 84 , 265 – 269 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Holzmayer , T. A. , Hilsenbeck , S. , von Hoff , D. D. and Roninson , I. B.Clinical correlates of MDR1 (P‐glycoprotein) gene expression in ovarian and small‐cell lung carcinomas . J. Natl. Cancer Inst ., 84 , 1486 – 1491 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 9.Heike , Y. , Hamada , H. , Inamura , N. , Sone , S. , Ogura , T. and Tsuruo , T.Monoclonal anti‐P‐glycoprotein antibody‐dependent killing of multidrug‐resistant tumor cells by human mononuclear cells . Jpn. J. Cancer Res ., 81 , 1155 – 1161 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Nishioka , Y. , Sone , S. , Heike , Y. , Hamada , H. , Ariyoshi , K. , Tsuruo , T. and Ogura , T.Effector cell analysis of human multidrug‐resistant cell killing by mouse‐human chimeric antibody against P‐glycoprotein . Jpn. J. Cancer Res ., 83 , 644 – 649 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Tsuruo , T. , Hamada , H. , Sato , S. and Heike , Y.Inhibition of multidrug‐resistant human tumor growth in athymic mice by anti‐P‐glycoprotein monoclonal antibodies . Jpn. J. Cancer Res ., 80 , 627 – 631 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Munn , D. H. and Cheung , N. K. V.Antibody‐dependent antitumor immunity cytotoxicity by human monocytes cultured with recombinant macrophage colony stimulating factor. Induction of efficient antibody‐mediated antitumor cytotoxicity not detected by isotope release assays . J. Exp. Med ., 170 , 511 – 521 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Suzu , S. , Yanai , N. , Saito , M. , Kawashima , T. , Kasahara , T. , Saito , M. , Takaku , F. and Motoyoshi , K.Enhancement of the antibody‐dependent tumoricidal activity of human monocytes by human monocytic colony‐stimulating factor . Jpn. J. Cancer Res ., 81 , 79 – 84 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Mufson , R. A. , Aghajanian , J. , Wong , G. , Woodhouse , C. and Morgan , A. C.Macrophage colony‐stimulating factor enhances monocyte and macrophage antibody‐dependent cell‐mediated cytotoxicity . Cell. Immunol ., 119 , 182 – 192 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 15.Heike , Y. , Sone , S. , Yano , S. , Seimiya , H. , Tsuruo , T. and Ogura , T.M‐CSF gene transduction in multidrug‐resistant human cancer cells to enhance anti‐P‐glycoprotein antibody‐dependent macrophage‐mediated cytotoxicity . Int. J. Cancer , 54 , 851 – 857 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 16.Hamada , H. , Miura , K. , Ariyoshi , K. , Heike , Y. , Sato , S. , Kameyama , K. , Kurosawa , Y. and Tsuruo , T.Mouse‐human chimeric antibody against the multidrug transporter P‐glycoprotein . Cancer Res ., 50 , 3167 – 3171 ( 1990. ). [PubMed] [Google Scholar]
  • 17.Takahashi , M. , Hirato , T. , Takano , M. , Nishida , T. , Nagamura , K. , Kamogashira , T. , Nakai , S. and Hirai , Y.Amino‐terminal region of human macrophage colony‐stimulating factor (M‐CSF) is sufficient for its in vitro biological activity: molecular cloning and expression of carboxyl‐terminal deletion mutants of human M‐CSF . Biochem. Biophys. Res. Commun ., 161 , 892 – 901 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 18.Wigler , M. , Peilicer , A. , Silverstein , S. , Axel , R. , Urlaub , G. and Chasin , L.DNA‐mediated transfer of the adenine phosphoribosyl‐transferase locus into mammalian cells . Proc. Natl. Acad. Sci. USA , 76 , 1373 – 1376 ( 1979. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Sone , S. , Nakanishi , M. , Ohmoto , Y. , Yanagawa , H. and Ogura , T.Macrophage colony‐stimulating factor activity in malignant pleural effusions and its augmentation by intrapleural interleukin‐2 infusions . Chest , 99 , 377 – 381 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 20.Dillman , R. O.Antibodies as cytotoxic therapy . J. Clin. Oncol ., 12 , 1497 – 1515 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 21.Evans , R.Macrophage requirement for growth of a murine fibrosarcoma . Br. J. Cancer , 37 , 1086 – 1089 ( 1978. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Nathan , C. F. and Terry , W. D.Differential stimulation of murine lymphoma growth in vitro by normal and BCG‐activated macrophages . J. Exp. Med ., 142 , 887 – 902 ( 1975. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Mantovani , A. , Bottazzi , B. , Colotta , F. , Sozzani , S. and Ruco , L.The origin and function of tumor‐associated macrophages . Immunol. Today , 13 , 265 – 270 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 24.Sampson‐Johannes , A. and Carlino , J. A.Enhancement of human monocyte tumoricidal activity by recombinant M‐CSF . J. Immunol ., 141 , 3680 – 3686 ( 1988. ). [PubMed] [Google Scholar]
  • 25.Chambers , S.K. , Wang , Y. , Gertz , R.E. and Kacinski , B. M.Macrophage colony‐stimulating factor mediates invasion of ovarian cancer cells through urokinase . Cancer Res ., 55 , 1578 – 1585 ( 1995. ). [PubMed] [Google Scholar]
  • 26.Kacinski , B. M. , Stanley , E. R. , Carter , D. , Chambers , J. T. , Chambers , S. K. , Kohorn , E. I. and Schwartz , P. E.Circulating levels of CSF‐1 (M‐CSF) a lymphohematopoietic cytokine may be a useful marker of disease status in patients with malignant ovarian neoplasms . Int. J. Radiat. Oncol. Biol. Phys ., 17 , 159 – 164 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 27.Hume , D. A. , Donahue , R. and Fidler , I. J.The therapeutic effect of human recombinant macrophage colony‐stimulating factor (CSF‐1) in experimental murine metastatic melanoma . Lymphokine Res ., 8 , 69 – 77 ( 1989. ). [PubMed] [Google Scholar]
  • 28.Bock , S. N. , Cameron , R. B. , Kragel , P. , Mule , J. J. and Rosenberg , S. A.Biological and antitumor effects of recombinant human macrophage colony‐stimulating factor in mice . Cancer Res ., 51 , 2649 – 2654 ( 1991. ). [PubMed] [Google Scholar]
  • 29.Asher , A. L. , Mule , J. J. , Kasid , A. , Restifo , N. P. , Salo , J. C. , Reichert , C. M. , Jaffe , G. , Fendly , B. , Kriegler , M. and Rosenberg , S. A.Murine tumor cells transduced with the gene for tumor necrosis factor‐α . J. Immunol ., 146 , 3227 – 3234 ( 1991. ). [PMC free article] [PubMed] [Google Scholar]
  • 30.Anderson , W. F.Human gene therapy . Science , 256 , 808 – 813 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 31.Golumbek , P. T. , Lazenby , A. J. , Levitsky , H. I. , Jaffee , L. M. , Karasuyama , H. , Baker , M. and Pardoll , D. M.Treatment of established renal cancer by tumor cells engineered to secrete interleukin‐4 . Science , 254 , 713 – 716 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 32.Mulligan , R. C.The basic science of gene therapy . Science , 260 , 926 – 932 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 33.Zhu , N. , Liggitt , D. and Debs , R.Systemic gene expression after intravenous DNA delivery into adult mice . Science , 261 , 209 – 211 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 34.Hyde , S. , Gill , D. R. , Higgins , C. F. and Trezise , A. E. O.Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy . Nature , 362 , 250 – 255 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 35.Thierry , A. R. , Lunardi‐Iskandar , Y. , Bryant , J. L. , Rabinovich , P. , Gallo , R. C. and Mahan , L. C.Systemic gene therapy: biodistribution and long‐term expression of a transgene in mice . Proc. Natl. Acad. Sci. USA , 92 , 9742 – 9746 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES